Back

Mesenchymal stromal-like cells (MLCs) derived from induced pluripotent stem (iPS) cells: a promising therapeutic option to promote neovascularization

9 July 2016 (08:30 - 18:00)
Organised by: Logo
Congress Presentation Part of: Poster session 2 - Cell growth, differentiation and stem cells - Vascular Cell growth, differentiation and stem cells - Vascular Open Access Frontiers in CardioVascular Biology 2016 Council on Basic Cardiovascular Science

About the speaker

Photo
Doctor Raquel Ferrer-Lorente

Center of Regenerative Medicine in Barcelona, Spain. CIBER-BBN. Cardiovascular Research Center., Barcelona (Spain)

4 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Professor J. Hsu (Kaohsiung, TW)
Abstract
Presentation thumbnail
Miss M. Alshamrani (Dublin, IE)
Abstract
Presentation thumbnail

Access the full session

Session thumbnail
Poster session 2 - Cell growth, differentiation and stem cells - Vascular

The Event

Event poster

Frontiers in CardioVascular Biology 2016

9 July 2016 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Extracellular vesicles from mesenchymal stromal cells combined with tissue engineering for myocardial repair
29 June 2021
thumbnail
Congress Presentation
iPSC-derived cardiomyocytes as a model to dissect ion current alterations of genetic atrial fibrillation
8 July 2016
thumbnail
Congress Session
Metabolic control of angiogenesis
29 August 2022
thumbnail
Congress Presentation
Role of osteogenic circulating endothelial progenitor cells in dissemination of large arterial calcification in rheumatoid arthritis
2 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources